The silencing of actin capping protein ß2, Capzb2, by RNAi in developing cultured neurons results in short, dystrophic neurites reminiscent of cytoskeletal changes seen in diverse neurodegenerative diseases, including Alzheimer's disease (AD) and Huntington's disease (HD). Actin and tubulin are two major cytoskeletal proteins indispensable for normal neurite development and regenerative responses to injury and neurodegenerative stimuli. We have previously shown that Capzb2 binds tubulin and, in the presence of microtubule-associated protein tau, affects microtubule polymerization necessary for neurite outgrowth and normal growth cone morphology. Accordingly, Capzb2 silencing in hippocampal neurons results in short neurites with abnormal growth cones. Decreased neurite length is found in both AD and HD. In the first step towards uncovering the possible role of Capzb2 in these diseases, we studied Capzb2 protein expression in the postmortem brains of AD and HD patients. To determine whether disease-specific changes in Capzb2 protein accompany the progression of neurodegeneration, we performed Western Blot analysis of prefrontal cortices (PFC) and hippocampi (HPC) in AD patients and of PFC and heads of caudate nuclei (HCN) in HD patients. Our results show disease-and areaspecific dynamics in the levels of Capzb2 protein expression in the progressive stages of AD and HD .
introduction
Abnormalities in the cytoskeleton are found in many neurodegenerative diseases including AD. How these abnormalities affect neurodegeneration remains unclear.
In Drosophila, neurodegeneration stems directly from mutations in alpha and beta subunits of the actin capping protein (CP), demonstrating that a mutation in a gene encoding an actin cytoskeleton regulator can lead to the demise of neurons [1] . Recently, we showed that RNAimediated silencing of the actin capping protein ß2 subunit (Capzb2) in cultured hippocampal neurons resulted in short, dystrophic neurites [2] reminiscent of cytoskeletal changes associated with neurodegeneration in AD and HD. Interestingly, apolipoprotein E4 isoform (apoE4), the only confirmed genetic risk factor for late onset AD [3] , inhibits neurite outgrowth in cultured neuronal cells [4] , while the simplification of dendritic branching patterns in the brains of AD patients correlates with the presence of apoE4 allele [5] . Furthermore, amyloid precursor protein (APP), similar to Capzb2, is concentrated in lamellipodia [6] , consistent with the idea that APP may play a role in growth cone motility and neurite outgrowth.
The targets of the aggregations initiated by the interaction with mutant huntingtin are considered responsible for the neuronal morbidity in HD; these targets include cytoskeletal proteins [7] . Accordingly, dystrophic neurites containing mutant huntingtin are found in deep cortical layers of HD patients [8] . Moreover, decrease in neurite density and abnormal distribution of cytoskeletal markers by immunohistochemistry have been found in cortices of pre-symptomatic HD patients [9] .
These neuropathological findings are thought to underlie cognitive and behavioral disturbances that often precede motor deficits [10, 11] .
CP is an F-actin binding protein that functions as an a/ß heterodimer. By binding the barbed end of F-actin, the CP heterodimer blocks the access of actin monomers to the fast growing end.
Both Drosophila and mammalian CP subunits have been shown to play a critical role in the organization and dynamics of lamellipodia and filopodia in non-neuronal cells by regulating the actin cytoskeleton [12, 13] . In mammals, the ß-subunit is encoded by one gene that gives rise to three isoforms [14] ; one of these isoforms, Capzb2, is predominantly expressed in the brain [14] . While we have shown that Capzb2 function is indispensable for the normal morphology of growth cones and neurite length [2] , it remains unclear what Capzb2 expression may mean for neurons during neurodegenerative disease or following injury. The established first critical step in response to axotomy is the initiation of microtubule polymerization and F-actin cytoskeleton rearrangement leading to the formation of a motile growth cone [15] . We have demonstrated that Capzb2 in the growth cones not only caps the F-actin barbed end, but also binds ßIII-tubulin directly to affect the rate and extent of microtubule polymerization [2] . Interestingly, the interaction between actin capping protein and ß-tubulin has been uncovered in a mass spectrometry screen for the alterations in protein-target binding in vivo in response to spatial learning [16] .
In this study, we investigate the expression of 
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Results
In AD HPC (Figure 1 In the heads of caudate nuclei (HCN) of HD patients there was a uniform decrease in the Capzb2 expression (Figure 3) . Regardless of the stage of the disease, eight out of nine examined cases showed uniform decrease (on average -65%) in Capzb2 expression level in comparison to controls. In sharp contrast, in the majority of the cases (7 out of 9), the PFC showed increase in Capzb2 expression ranging from 110% to over 200% of the control level (Figure 4) . Thus,
Capzb2 expression in HD brains shows starkly divergent, region-specific trends.
Discussion
In the caudate nuclei of HD patients overall, [17] . The presence of growth cone-like structures on distal ends of processes has been interpreted as regenerative response occurring simultaneously with degenerative changes [17] . We found that the Capzb2 protein expression was increased in both the hippocampus and the prefrontal cortex of several AD patients. Previously we identified Capzb2 as a link between microfilament and microtubule assembly in the growth cone [2] .
Together, these data raise the possibility that Capzb2 may be involved in morphological changes associated with regenerative response in neurons.
We found that Capzb2 protein levels exhibit diverging trends in the head of caudate nucleus (HCN) and the prefrontal cortex (PFC) during the progression of HD (Figures 3 and 4) .
A profound decrease in Capzb2 expression is noted at the earliest HD grade grossly diagnosable by the atrophy of the medial paraventricular portion of the caudate nucleus (Vonsattel grade 2/4) [18] . At this stage there is a severe neuronal loss (>50%) [18] , which could explain the approximately 50% reduction in Capzb2 expression in HCN (Figure 3) . However,
PFCs of the same patients exhibit increased
Capzb2 expression (Figure 4) . PFC pyramidal neurons of layers III and V in HD patients have been found to augment their dendritic tree [19] . Translational Neuroscience
